These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25070041)

  • 1. Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes.
    Görgens C; Guddat S; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1102-7. PubMed ID: 25070041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of myo-inositol trispyrophosphate in equine urine and plasma by hydrophillic interaction chromatography-tandem mass spectrometry.
    Wong AS; Ho EN; Wan TS
    Drug Test Anal; 2012 May; 4(5):355-61. PubMed ID: 22359395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
    Görgens C; Guddat S; Orlovius AK; Sigmund G; Thomas A; Thevis M; Schänzer W
    Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP.
    Lam G; Zhao S; Sandhu J; Yi R; Loganathan D; Morrissey B
    Drug Test Anal; 2014 Mar; 6(3):268-76. PubMed ID: 23733541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping control analysis of myo-inositol trispyrophosphate and 10 bisphosphonates in equine plasma by ion chromatography-mass spectrometry and its application to clodronic acid horse administration.
    Wong ASY; Yuen BP; Wong COL; Kong FK; So YM; Kwok WH; Brooks L; Wan TSM; Ho EN
    Drug Test Anal; 2024 Jun; ():. PubMed ID: 38924320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous analysis of 210 prohibited substances in human urine by ultrafast liquid chromatography/tandem mass spectrometry in doping control.
    Jeong ES; Kim SH; Cha EJ; Lee KM; Kim HJ; Lee SW; Kwon OS; Lee J
    Rapid Commun Mass Spectrom; 2015 Feb; 29(4):367-84. PubMed ID: 26406349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry.
    Periat A; Kohler I; Thomas A; Nicoli R; Boccard J; Veuthey JL; Schappler J; Guillarme D
    J Chromatogr A; 2016 Mar; 1439():42-53. PubMed ID: 26387791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for benfluorex and its major urinary metabolites in routine doping controls.
    Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. myo-Inositol trispyrophosphate: a novel allosteric effector of hemoglobin with high permeation selectivity across the red blood cell plasma membrane.
    Duarte CD; Greferath R; Nicolau C; Lehn JM
    Chembiochem; 2010 Dec; 11(18):2543-8. PubMed ID: 21086482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
    Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the quantification of ephedrines using medium-resolution accurate mass spectrometry.
    Gray N; Heaton J; Musenga A; Cowan DA; Plumb RS; Smith NW
    J Chromatogr A; 2013 May; 1289():37-46. PubMed ID: 23570855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive hydrophilic interaction liquid chromatography/tandem mass spectrometry method for rapid detection, quantification and confirmation of cathinone-derived designer drugs for doping control in equine plasma.
    Li X; Uboh CE; Soma LR; Liu Y; Guan F; Aurand CR; Bell DS; You Y; Chen J; Maylin GA
    Rapid Commun Mass Spectrom; 2014 Jan; 28(2):217-29. PubMed ID: 24338970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
    Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
    Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
    Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-tandem mass spectrometry screening method for the simultaneous detection of stimulants and diuretics in urine.
    Hsu KF; Chien KY; Chang-Chien GP; Lin SF; Hsu PH; Hsu MC
    J Anal Toxicol; 2011 Nov; 35(9):665-74. PubMed ID: 22080905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.